Drug Research

The Promise of Stem Cell Research Yields Double-Digit Growth Rates, Reports BCC Research

Wellesley, June 03, 2016: Although products based on stem cells have yet to form an established market, unlike some other…

9 years ago

Two presentations highlighting Zydus’ drug, Lipaglyn™ will be featured at the AACE Annual meeting

Ahmedabad, May 26, 2016: The Zydus group, a leading global healthcare provider announced that new clinical data on Lipaglyn™ (Saroglitazar) will…

9 years ago

Popularity of Aceglutamide to Increase in the Wake of Growing Need for Central Stimulant Drugs – Ken Research

Bengaluru, Mary 12, 2016: Ken Research introduces its latest publication on, “Market Research Report on Aceglutamide in China, 2010-2019” which offers detailed insights into…

9 years ago

Certification for New TB Drug

New Delhi, April 27, 2016:World Health Organization has made conditional recommendation for use of Bedaquiline for treatment of Multi drug…

9 years ago

Generic Drugs in Rural Areas

New Delhi, April 27, 2016:Public Health is a state subject. Under the National Health Mission (NHM), support is provided to…

9 years ago

Doctors Advocate Adoption of Better Diagnostic Algorithms to Fight Multi Drug Resistant TB

New Delhi, March 30, 2016: With multi-drug resistant tuberculosis emerging as a major obstacle in the fight against tuberculosis, doctors…

9 years ago

Indian Health Ministry Ends Repeat Animal Testing for Drugs

New Delhi, March 21, 2016: Repeat animal testing of new drugs already tested abroad is now banned per a ruling…

9 years ago

Gelusil liquid antacid now available in a handy ready-to-consume sachet

  Delhi, March 04, 2016: Pfizer’s GEP (Global Established Products) division in India announced the launch of its largest selling…

9 years ago

Cyclopharm Ltd, Bldg 75 Business & Technology Park New Illawarra Road Lucas Heights NSW 2234 Australia PO Box 350, Menai Central NSW 2234 Australia

Name : Cyclopharm Ltd Address : Bldg 75 Business & Technology Park New Illawarra Road Lucas Heights NSW 2234 Australia…

9 years ago

Stempeutics receives Orphan Drug Designation (ODD) in the European Union for its novel stem cell drug “Stempeucel®” for the treatment of ThromboangiitisObliterans

The first allogeneic stem cell drug to be granted ODD status by European Medicinal Agency (EMA) for treating ThromboangiitisObliterans Stempeucel…

9 years ago